Table 2.
Compound Name | specific activity (nmol/mg-min) | H37Ra | SRICK1 | SRICK1::adoK |
---|---|---|---|---|
MICa(μg/ml) | ||||
5′-amino-5′-deoxy-Ado | NDb | >100 | >100 | >100 |
9-[β-D-5-methyl-(allo)-ribofuranosyl]-2-fluoro-adenine | 4 | 1–10 | >50 | 0.1–1 |
9-[α-L-lyxofuranosyl]-2-fluoro-adenine | 130 | 10–100 | >100 | 10–100 |
MIC assays were performed at least twice for each compound.
ND specific activity was not determined for this compound.